济川药业
(600566)
| 流通市值：237.75亿 | | | 总市值：238.47亿 |
| 流通股本：9.19亿 | | | 总股本：9.21亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,328,315,675.24 | 1,207,498,577.63 | 6,218,642,450.8 | 3,932,057,245.53 |
| 营业总成本 | 1,661,814,776.88 | 832,970,181.7 | 4,311,082,171.03 | 2,887,618,682.39 |
| 其他经营收益 | | | | |
| 营业利润 | 929,124,632.58 | 473,047,371.89 | 2,157,753,144.21 | 1,255,128,353.42 |
| 利润总额 | 931,851,188.55 | 474,170,427.99 | 2,162,256,551.35 | 1,260,406,214.76 |
| 净利润 | 782,017,148.28 | 399,066,859.89 | 1,778,264,104.2 | 1,024,117,001.86 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 782,017,148.28 | 399,066,859.89 | 1,778,264,104.2 | 1,024,117,001.86 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 13,437,763,348.13 | 14,216,926,102.9 | 14,180,194,109.23 | 12,945,450,807.22 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,571,206,069.21 | 3,620,187,487.25 | 3,520,064,388.12 | 3,588,080,734.59 |
| 资产总计 | 17,008,969,417.34 | 17,837,113,590.15 | 17,700,258,497.35 | 16,533,531,541.81 |
| 流动负债: | | | | |
| 流动负债合计 | 2,975,570,711.19 | 2,604,839,843.22 | 2,875,767,092.77 | 2,431,672,741.26 |
| 非流动负债: | | | | |
| 非流动负债合计 | 218,343,439.49 | 217,418,758.89 | 191,832,597.94 | 244,094,172.91 |
| 负债合计 | 3,193,914,150.68 | 2,822,258,602.11 | 3,067,599,690.71 | 2,675,766,914.17 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 13,790,153,970.08 | 14,988,820,535.03 | 14,605,549,345.96 | 13,829,413,055.71 |
| 股东权益合计 | 13,815,055,266.66 | 15,014,854,988.04 | 14,632,658,806.64 | 13,857,764,627.64 |
| 负债和股东权益合计 | 17,008,969,417.34 | 17,837,113,590.15 | 17,700,258,497.35 | 16,533,531,541.81 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,477,176,984.34 | 2,496,748,895.71 | 6,756,669,077.45 | 5,278,586,814.38 |
| 经营活动现金流出小计 | 2,622,631,186.14 | 1,616,409,196.99 | 5,558,374,833.55 | 4,575,075,444.98 |
| 经营活动产生的现金流量净额 | 854,545,798.2 | 880,339,698.72 | 1,198,294,243.9 | 703,511,369.4 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,484,003,552.57 | 1,480,767,569.43 | 5,713,804,410.79 | 4,458,764,474.94 |
| 投资活动现金流出小计 | 7,268,787,520.26 | 4,031,682,460.08 | 6,690,058,707.04 | 5,021,530,152.23 |
| 投资活动产生的现金流量净额 | -1,784,783,967.69 | -2,550,914,890.65 | -976,254,296.25 | -562,765,677.29 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,519,850,070.97 | 832,822,965.06 | 1,455,807,420.31 | 763,658,197.31 |
| 筹资活动现金流出小计 | 2,280,141,344.08 | 672,696,016.92 | 2,908,076,555.9 | 2,443,868,329.63 |
| 筹资活动产生的现金流量净额 | -760,291,273.11 | 160,126,948.14 | -1,452,269,135.59 | -1,680,210,132.32 |
| 汇率变动对现金及现金等价物的影响 | -25,936.6 | -10,367.13 | -9,939.83 | - |
| 现金及现金等价物净增加额 | -1,690,555,379.2 | -1,510,458,610.92 | -1,230,239,127.77 | -1,539,464,440.21 |
| 期末现金及现金等价物余额 | 3,748,568,236.74 | 3,928,665,005.02 | 5,439,123,615.94 | 5,129,898,303.5 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -1,690,555,379.2 | - | -1,230,239,127.77 | - |
最新报告期：2026-08-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国金证券 | 王奔奔,甘坛焕 | 1.94 | 2.11 | 2.36 | 2026-08-30 |